|
|
Post by anderson on Jun 6, 2017 18:08:26 GMT -5
Why didn't Hakan do this years ago? Just sayin'. Could be that MNKD didnt have any drug candidates far enough in the pipeline to shop around to perspective partners. |
|
|
|
Post by mnholdem on Jun 6, 2017 18:27:07 GMT -5
I believe that both Hakan and Matt have separately stated that MannKind's Technosphere API would need to reach the IND stage before partners typically take interest in funding continued API development. CMO Urbanski had a pre-IND meeting with the FDA in December for Epinephrine (Technosphere). I don't think the wait will be much longer.  |
|
